Literature DB >> 16287791

The relationship between condom use and herpes simplex virus acquisition.

Anna Wald1, Andria G M Langenberg, Elizabeth Krantz, John M Douglas, H Hunter Handsfield, Richard P DiCarlo, Adaora A Adimora, Allen E Izu, Rhoda Ashley Morrow, Lawrence Corey.   

Abstract

BACKGROUND: Few studies have evaluated the relationship between condom use and herpes simplex virus type 2 (HSV-2) and HSV type 1 (HSV-1) acquisition.
OBJECTIVE: To assess the relationship between condom use and acquisition of HSV-2 and HSV-1 among men and women.
DESIGN: Analysis of data collected as part of a clinical trial of an ineffective candidate vaccine for HSV-2.
SETTING: Sexually transmitted disease clinics. PARTICIPANTS: Men and women at risk for HSV-2 acquisition, defined as having 4 or more sexual partners or having a sexually transmitted disease in the past year. MEASUREMENT: Acquisition of HSV-2 and HSV-1 as measured by viral culture or change to positive HSV serostatus.
RESULTS: Of 1843 participants, 118 (6.4%) became infected with HSV-2. In multivariate analyses, participants reporting more frequent use of condoms were at lower risk for acquiring HSV-2 than participants who used condoms less frequently (hazard ratio, 0.74 [95% CI, 0.59 to 0.95]); categories of increasing condom use were 0% to 25%, 25% to 75%, and greater than 75% of sexual acts. Nineteen (2.9%) of 659 participants at risk for infection with HSV-1 became infected. No statistically significant association between condom use and infection with HSV-1 was found (hazard ratio, 0.79 [CI, 0.48 to 1.31]). LIMITATIONS: Use of condoms was measured by self-report, and persons who used condoms may have differed from those who did not.
CONCLUSIONS: Consistent use of condoms is associated with lower rates of infection with HSV-2 and should be routinely recommended.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16287791     DOI: 10.7326/0003-4819-143-10-200511150-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  41 in total

1.  Are condoms the answer to rising rates of non-HIV sexually transmitted infections? Yes.

Authors:  Markus J Steiner; Willard Cates
Journal:  BMJ       Date:  2008-01-26

Review 2.  Genital herpes.

Authors:  Eva Maria Agnes Jungmann
Journal:  BMJ Clin Evid       Date:  2007-04-01

3.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

Review 4.  Genital herpes.

Authors:  Lisa M Hollier; Heather Straub
Journal:  BMJ Clin Evid       Date:  2011-04-15

5.  Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents.

Authors:  Staci L Sudenga; Mirjam-Colette Kempf; Gerald McGwin; Craig M Wilson; Edward W Hook; Sadeep Shrestha
Journal:  Sex Transm Dis       Date:  2012-04       Impact factor: 2.830

6.  High Rates of Herpes Simplex Virus Type 2 Infection in Homeless Women: Informing Public Health Strategies.

Authors:  J Daniel Kelly; Jennifer Cohen; Barbara Grimes; Susan S Philip; Sheri D Weiser; Elise D Riley
Journal:  J Womens Health (Larchmt)       Date:  2016-05-31       Impact factor: 2.681

7.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

8.  Predictors of using a microbicide-like product among adolescent girls.

Authors:  Mary B Short; Paul A Succop; Ana M Ugueto; Susan L Rosenthal
Journal:  J Adolesc Health       Date:  2007-07-20       Impact factor: 5.012

9.  Phase I dose-escalation study of a monovalent heat shock protein 70-herpes simplex virus type 2 (HSV-2) peptide-based vaccine designed to prime or boost CD8 T-cell responses in HSV-naïve and HSV-2-infected subjects.

Authors:  David M Koelle; Amalia Magaret; Christopher L McClurkan; Michael L Remington; Terri Warren; Florentina Teofilovici; Anna Wald
Journal:  Clin Vaccine Immunol       Date:  2008-03-19

10.  Suppressive valacyclovir therapy to reduce genital herpes transmission: good public health policy?

Authors:  Paul E Bonnar
Journal:  Mcgill J Med       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.